| Ytd | 15.85% | |
| 1y | 55.95% |
| Open | 171.40 | Prev Close | 170.89 | Low | 171.40 | High | 192.14 | Mkt Cap | 1.31B |
| Vol | 215.05K | Avg Vol | 158.14K | EPS | 13.67 | P/E | 13.95 | Forward P/E | 9.38 |
| Beta | 2.06 | Short Ratio | 8.64 | Inst. Own | 42.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 133.84 | 200-d Avg | 125.96 | 1yr Est | 246.40 |
Nutex Health is rated Buy, with a DCF-based price target of $199.31, offering 19.8% upside from $166
B. Riley Securities analyst Anderson Schock initiates coverage on Nutex Health (NASDAQ:NUTX) with
Lake Street analyst Ben Haynor initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating